Correction: Intensive care unit versus high-dependency care unit admission on mortality in patients with septic shock: a retrospective cohort study using Japanese claims data

Table 5 Primary outcome and secondary outcomes

Primary outcome	Overall	ICU	HDU	Point estimates	95% CI	P value
30-day mortality	2602 (24.0)	1576 (23.9)	1026 (24.2)	0.89^a	0.83–0.96	0.005
Secondary outcomes
In-hospital death	3308 (30.6)	2041 (31.0)	1267 (29.9)	0.82^b	0.75–0.90	< 0.001
Hospital length of stay, days	25.0 (13.0–46.0)	26.0 (14.0–48.0)	22.0 (12.0–43.0)	− 0.31^c	− 1.92 to 1.28	0.69
ICU or HDU length of stay, days	6.0 (3.0–13.0)	7.0(4.0–14.0)	5.0 (3.0–10.0)	0.11^c	− 0.09 to 0.31	0.29
Discharge to home	3504 (32.4)	2036 (30.9)	1468 (34.7)	1.03^b	0.94–1.14	0.42
Discharge to other hospitals	3501 (32.4)	2289 (34.8)	1212 (28.6)	1.20^b	1.09–1.31	< 0.001
Discharge to nursing home	1310 (12.1)	812 (12.3)	498 (11.8)	1.12^b	0.95–1.31	0.15
Barthel index on discharge^§	50.0 (0.0–100.0)	50.0 (0.0–100.0)	45.0 (0.0–100.0)	2.32^c	0.12–4.53	0.038

Data are presented as number of events (%) or mean (IQR)
IQR interquartile range, CI confidence interval, CRRT continuous renal replacement therapy, PMX-DHP polymyxin B immobilized fiber column direct hemoperfusion, VA-ECMO venoatrial extracorporeal membrane oxygenation, IABP intra-aortic balloon pumping
^§The number of patients missing Barthel index: ICU 2499, HDU 1529
^aAdjusted HR adjusted for age, sex, Charlson comorbidity index, admission year, ambulance use, teaching hospitals, emergency charge, hospital beds, patients from nursing home, source of infection, drainage, surgery, mechanical ventilation, CRRT, PMX-DHP, VA-ECMO, use of two or more catecholamines, transfusions (red blood cell, platelet, fresh frozen plasma), albumin, globulin, sedatives drugs, opioids drugs, recombinant thrombomodulin, antithrombin III, and hydrocortisone
^bAdjusted odds ratio adjusted for the same covariates as ^a
^cRegression coefficient adjusted for the same covariates as ^a

ISSN: 2052-0492